Sarepta Therapeutics | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 40.25M 1.6M 2025-06
Amgen USD 694M 29M 2025-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Daiichi Sankyo 1.42B 5.66B 2025-06
Eli Lilly USD 243.7M 19M 2025-03
Gilead Sciences USD 260M 12M 2025-03
Incyte USD 594K 66K 2025-06
Insmed USD 21.24M 1.5M 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Pfizer USD 654M 0 2025-06
PTC Therapeutics USD 34.39M 8.96M 2025-03
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 148M 65M 2025-06
Sarepta Therapeutics USD 5.23M 725K 2025-06
Tectonic Therapeutic USD 22K 3K 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 3.7M 900K 2025-06


Sarepta Therapeutics Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.